Revolution Medicines, Inc. RVMD Intangible Amortization
Intangible Amortization at other companies
Other financials
Where this comes from
Reported directly by Revolution Medicines, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AmortizationOfIntangibleAssets.
The official record: Revolution Medicines, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Revolution Medicines, Inc.'s intangible amortization.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Revolution Medicines, Inc.'s intangible amortization?
- Revolution Medicines, Inc. (RVMD) reported intangible amortization of $0 in Q1 2026.
- How has Revolution Medicines, Inc.'s intangible amortization changed year-over-year?
- Revolution Medicines, Inc.'s intangible amortization decreased by 100.0% year-over-year, from $267K to $0.
- What is the long-term trend for Revolution Medicines, Inc.'s intangible amortization?
- Over 4 years (2021 to 2025), Revolution Medicines, Inc.'s intangible amortization has grown at a -4.7% compound annual growth rate (CAGR), from $1.13M to $936K.
- What does intangible amortization mean?
- The non-cash expense representing the gradual write-down of intangible assets.
- How do you interpret intangible amortization?
- Higher amortization reflects significant past investments in intellectual property or acquisitions.
- How does intangible amortization compare across companies?
- Standard for biotech and tech firms with significant intellectual property portfolios.